View Older Stories View More Recent Stories
-
Robertson Stephens Expands Investment Management Group, Robertson Stephens Partners LLC
-
Roth Affirms Flex Pharma (FLKS) at 'Buy' Following Positive NLC POC Data
-
Roth Capital Starts Mellanox Technologies (MLNX) at Buy
-
Streetinsider.com's Hot Lunchtime Reads 2/1: (JPM) (CSIQ) (BABA) (AAPL)
-
Canadian Solar (CSIQ) has Attractive Risk-Reward Below pre-ITC Extension Levels - Roth Capital
-
Current Valuation on Aduro Biotech (ADRO) Doesn't Appreciate Upcoming Opportunities - Roth Capital
-
Roth Capital Downgrades Outerwall Inc. (OUTR) to Neutral
-
Tearlab (TEAR) to Offer $15M in Common Stock
-
TearLab Announces Proposed Public Offering of Common Stock
-
8point3 Energy (CAFD) is Built to Last; Roth Affirms at 'Buy'
-
Roth Affirms SolarCity (SCTY) at 'Buy' as CPUC Passes NEM 2.0
-
Initial Read of Revised NEM PD Better than Expected; Roth Affirms SolarCity (SCTY) at 'Buy'
-
NEM 2.0 Decision Key for SolarCity (SCTY), But Risk-Reward Becoming Favorable - Roth
-
Roth Capital Starts First Solar (FSLR) at Buy
-
Aqua Metals Issues Annual Letter to Shareholders
-
Roth Reiterates Ligand Pharma (LGND) at 'Buy' Following Additional Kyprolis Approval
-
Roth Capital Remains Positive on Peregrine Pharma (PPHM) for 2016; Reaffirms at 'Buy'
-
Streetinsider.com's Hot Lunchtime Reads 1/19: (CMG) (ADMS) (TSLA) (SUNE)
-
Roth Capital Remains Confident on 2016 Thesis for Cytokinetics (CYTK) Following Recent Mgmt Meetings
-
Roth Capital Upgrades Regeneron Pharma (REGN) to Buy
-
Global Water Resources, Inc. Announces Filing of Registration Statement with the SEC
-
The PIPEs Report Sees Second Largest Year for Small-Cap Equity Financing Capital Since 2001
-
Roth Capital Says MeetMe's (MEET) Weakness is Related to Selling From Large Legacy Shareholder - Reiterates Buy
-
Streetinsider.com's Hot Lunchtime Reads 1/13: (ESRX) (MSFT) (AAPL) (LGND)
-
Roth Capital Impressed by Speed of Ligand (LGND) Capitalizing on OMT Acquisition; Affirms at 'Buy'
-
PlacementTracker Publishes 2015 PIPE Market League Tables
-
Roth Positive on BioLineRx (BLRX) and Merck's BL-8040 + KEYTRUDA Collaboration
-
Roth Capital Cuts PT Due to Natus Medical's (BABY) Light 2016 Outlook Following Venezuela Contract Delay
-
Roth Capital Slashes PT on Skullcandy (SKUL) to $5.50; Move to Wireless Could Still Pressure Shares
-
Low Production at Rochester Offset Results for Coeur Mining's (CDE) 4Q - Roth Capital Cuts PT to $6
-
Eilers Research Announces Name Change to “Eilers & Krejcik Gaming, LLC”
-
Highpower Special Committee Engages Financial Advisor and Legal Counsel
-
Roth Capital Cuts Price Target on Synergy Resources (SYRG) to $13 Following 1Q Results
-
Roth Capital Still Values Flamel Technologies (FLML) Following Revisions - Cuts PT to $17.50
-
Low Membership Income Hurts PriceSmart's (PSMT) 1Q - Roth Capital Cuts PT to $85
-
Galena Biopharma (GALE) Prices 19.8M Common Stock and Warrant Offering at $1.10/Unit
-
Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants
-
Roth Slashes PT on TetraLogic (TLOG) to $1 as Two Studies Show Negative Results
-
Roth Capital Weighs in on uniQure (QURE) After First Human Positive Hemophilia B Data
-
Roth Capital Raises Price Target on MeetMe (MEET) Following Pre-Announced Upside
-
Roth Capital Reiterates Buy Following Conatus Pharmaceuticals (CNAT) Phase II Emricasan Data
-
Roth Capital Remains Bullish as Flex Pharma (FLKS) Completes NLC Enrollment
-
General Employment (JOB) Ends Year with 4th Acquisition of 2015 - Roth Capital Reiterates Buy
-
Roth Capital Starts Intevac (IVAC) at Buy, $8.50 PT
-
A Positive Pre-Announcement Keeps Roth Capital Bullish on GigOptix (GIG) - PT to $5
-
Roth Capital Remains Bullish as Channel Checks Suggest 4Q Rental Strength for Outerwall (OUTR)
-
Roth Capital Starts Planet Fitness (PLNT) at Buy
-
Unusual 11 Mid-Day Movers 12/31: (LEI) (TLOG) (PSTI) Higher; (INVT) (FLML) (OHGI) Lower
-
Roth Capital Maintains Buy on Flamel (FLML) Despite Earlier-Than-Expected Bloxiverz Competition
-
Notable Analyst Rating Changes 12/31: (OKE) Upgraded; (HPY) Downgraded

